These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8354295)

  • 1. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes.
    Orellana A; Holuigue L; Hidalgo PC; Faúndez V; González A; Bronfman M
    Eur J Biochem; 1993 Aug; 215(3):903-6. PubMed ID: 8354295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets.
    Bronfman M; Morales MN; Amigo L; Orellana A; Nuñez L; Cárdenas L; Hidalgo PC
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):289-95. PubMed ID: 1599408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme.
    Orellana A; Hidalgo PC; Morales MN; Mezzano D; Bronfman M
    Eur J Biochem; 1990 May; 190(1):57-61. PubMed ID: 2364949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
    Hong JT; Yun YP
    Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
    Graham MJ; Winham MA; Old SL; Gray TJ
    Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
    Li Y; Leung LK; Glauert HP; Spear BT
    Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
    Wilson MW; Leung LK; Hong JT; Glauert HP
    Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588
    [No Abstract]   [Full Text] [Related]  

  • 9. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
    Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK
    FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
    Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
    Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes.
    Hong JT; Glauert HP
    J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.
    Hong JT; Wilson MW; Glauert HP
    J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate.
    Leung LK; Glauert HP
    Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate.
    Bennett AM; Williams GM
    Biochem Pharmacol; 1993 Dec; 46(12):2219-27. PubMed ID: 8274155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
    Rao MS; Subbarao V
    Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate.
    Passilly P; Schohn H; Jannin B; Cherkaoui Malki M; Boscoboinik D; Dauça M; Latruffe N
    Biochem Pharmacol; 1999 Sep; 58(6):1001-8. PubMed ID: 10509752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
    Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
    Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of peroxisome proliferation in rainbow trout exposed to ciprofibrate.
    Yang JH; Kostecki PT; Calabrese EJ; Baldwin LA
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):476-82. PubMed ID: 2385837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the formation of PPARalpha-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration.
    Rodríguez C; Noé V; Cabrero A; Ciudad CJ; Laguna JC
    Mol Pharmacol; 2000 Jul; 58(1):185-93. PubMed ID: 10860941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.